Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer

被引:1333
作者
Siegel, PM [1 ]
Massagué, J [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Canc Biol & Genet Program, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nrc1208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cytostatic and apoptotic functions of transforming growth factor-beta (TGF-beta) help restrain the growth of mammalian tissues; loss of these effects leads to hyperproliferative disorders and is common in cancer. However, tumour cells that are relieved from TGF-beta growth constraints might then overproduce this cytokine to create a local immunosuppressive environment that fosters tumour growth and exacerbates the invasive and metastatic behaviour of the tumour cells themselves. For these reasons, there is a growing interest in understanding and therapeutically targeting TGF-beta-mediated processes in cancer progression.
引用
收藏
页码:807 / 820
页数:14
相关论文
共 177 条
  • [1] ALEXANDROW MG, 1995, CANCER RES, V55, P1452
  • [2] ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION
    ARTEAGA, CL
    HURD, SD
    WINNIER, AR
    JOHNSON, MD
    FENDLY, BM
    FORBES, JT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2569 - 2576
  • [3] Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
    Ashcroft, GS
    Yang, X
    Glick, AB
    Weinstein, M
    Letterio, JJ
    Mizel, DE
    Anzano, M
    Greenwell-Wild, T
    Wahl, SM
    Deng, CX
    Roberts, AB
    [J]. NATURE CELL BIOLOGY, 1999, 1 (05) : 260 - 266
  • [4] Bandyopadhyay A, 1999, CANCER RES, V59, P5041
  • [5] Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells
    Bandyopadhyay, A
    Zhu, Y
    Malik, SN
    Kreisberg, J
    Brattain, MG
    Sprague, EA
    Luo, J
    López-Casillas, F
    Sun, LZ
    [J]. ONCOGENE, 2002, 21 (22) : 3541 - 3551
  • [6] Transforming growth factor-β mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells
    Beck, PL
    Rosenberg, IM
    Xavier, RJ
    Koh, T
    Wong, JF
    Podolsky, DK
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (02) : 597 - 608
  • [7] Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
    Bhowmick, NA
    Ghiassi, M
    Bakin, A
    Aakre, M
    Lundquist, CA
    Engel, ME
    Arteaga, CL
    Moses, HL
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (01) : 27 - 36
  • [8] Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-Cdk2 and cyclin D2-Cdk4
    Blain, SW
    Montalvo, E
    Massague, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) : 25863 - 25872
  • [9] The recombinant proregion of transforming growth factor beta 1 (Latency-associated peptide) inhibits active transforming growth factor beta 1 in transgenic mice
    Bottinger, EP
    Factor, VM
    Tsang, MLS
    Weatherbee, JA
    Kopp, JB
    Qian, SW
    Wakefield, LM
    Roberts, AB
    Thorgeirsson, SS
    Sporn, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) : 5877 - 5882
  • [10] Böttinger EP, 1997, CANCER RES, V57, P5564